| NCT Number | NCT07460596 |
| Lead Sponsor | Tianjin Medical University Cancer Institute and Hospital |
| Conditions | Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Colon and Rectal Cancer |
| Enrollment | 30 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2023-12-31 (estimated) |
| Study Completion | 2024-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-10 |